404 papers found
A Phase 3 Study Comparing Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide With Continued TDF Treatment in Virologically Suppressed Patients With Chronic Hepatitis B: Week 48 Efficacy and Safety ResultsUpload
Efficacy and Safety Results 48 Weeks After Switching From Tenofovir Disoproxil Fumarate (Tdf) to Tenofovir Alafenamide (Taf) vs Continued TDF Treatment in Virologically-Suppressed Patients With Chronic Hepatitis B (Chb)Upload
Hep B Consult: A Point-of-Care Interactive Decision Support Tool Delivers Real-Time, Personalized, Guideline-Based Teaching and Reveals Variance Between Clinicians and Guidelines in the Management of HBV InfectionUpload
Missing publications? Search for publications with a matching author name.